Latest Breaking News On - Central nervous system disorders - Page 1 : comparemela.com

North America Active Pharmaceutical Ingredients Market Expected to Rise at 5.61% CAGR by 2032

The North America active pharmaceutical ingredients market size is projected to exhibit a growth rate (CAGR) of 5.61% during 2024-2032.

ACADIA Pharmaceuticals Inc CEO Stephen Davis Sells 26,574 Shares

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system disorders, has reported an insider sell transaction.

Patient Recruitment and Retention Services Global Market

Dublin, March 11, 2024 (GLOBE NEWSWIRE) The

Director Patrick Yang Sells 25,000 Shares of Sana Biotechnology Inc (SANA)

Director Patrick Yang has sold 25,000 shares of Sana Biotechnology Inc (NASDAQ:SANA), according to a recent SEC Filing.

Military Drone Market worth $23.57 billion by 2030, growing at